A diabetes, heart failure and kidney disease medication (sotagliflozin) is the first of its kind to significantly reduce both heart attacks and strokes
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart attack and…
Fatty muscles raise the risk of serious heart disease regardless of overall body weight
People with pockets of fat hidden inside their muscles are at a higher risk of dying or being hospitalised from a heart attack or heart failure, regardless of their body…
Researchers harness AI to predict cardiovascular risk from CT scans
Researchers at Case Western Reserve University, University Hospitals and Houston Methodist will harness the power of artificial intelligence (AI) to more accurately predict risk of heart failure and other cardiovascular…
Two thirds of deaths related to high BMI are due to cardiovascular diseases #ESCCongress #ESC24 #ESC2024
The ESC Clinical Consensus Statement on Obesity and Cardiovascular Disease, presented at this year’s ESC Congress (London, UK, 30 August to 2 September) summarises current evidence on the epidemiology and…
Women with endometriosis at greater associated risk of heart attack and stroke #ESCCongress #ESC24 #ESC2024
According to research presented at ESC Congress 2024 in London,1 women with endometriosis have a 20% greater risk of significant cardiac outcomes compared with women without endometriosis. “For decades, cardiovascular…
Five-minute test during routine GP appointments could prevent stroke
People at risk should be tested for atrial fibrillation every time they attend a health appointment, according to results of the AFFECT-EU project, which is holding its final event today…